These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 3131029

  • 1. [Fully supervised ambulatory short-course chemotherapy with an intermittent regimen for newly diagnosed smear-positive pulmonary tuberculosis].
    Xu RX.
    Zhonghua Jie He He Hu Xi Za Zhi; 1987 Oct; 10(5):261-3, 307. PubMed ID: 3131029
    [No Abstract] [Full Text] [Related]

  • 2. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
    Trébucq A, Rieder HL.
    Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189
    [No Abstract] [Full Text] [Related]

  • 3. [In 76% of patients with active tuberculosis treated with triple therapy (isoniazid-rifampicin-pyrazinamide) cultural conversion precedes microscopic conversion].
    Nowak D, Radenbach D, Magnussen H.
    Pneumologie; 1990 Feb; 44 Suppl 1():497-8. PubMed ID: 2114634
    [Abstract] [Full Text] [Related]

  • 4. Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up.
    Su WJ, Perng RP.
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):1029-32. PubMed ID: 12475151
    [Abstract] [Full Text] [Related]

  • 5. [A short course of chemotherapy in newly diagnosed and retreatment of smear-positive pulmonary tuberculosis in a rural area].
    Zhonghua Jie He He Hu Xi Za Zhi; 1989 Aug; 12(4):220-2, 254-5. PubMed ID: 2636947
    [Abstract] [Full Text] [Related]

  • 6. [Recent-term therapeutic effects of short-course chemotherapy in rural outpatients with smear positive tuberculosis].
    Zhang YD.
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Feb; 9(1):6-8, 61. PubMed ID: 3743281
    [No Abstract] [Full Text] [Related]

  • 7. [Effects of intermittent short-course chemotherapy under full-course supervision on the treatment of smear positive pulmonary tuberculosis].
    Yan S, Ye H, Lin S.
    Zhonghua Jie He He Hu Xi Za Zhi; 1996 Apr; 19(2):104-6. PubMed ID: 9388851
    [Abstract] [Full Text] [Related]

  • 8. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [Abstract] [Full Text] [Related]

  • 9. Fixed dose combination short course chemotherapy in the treatment of pulmonary tuberculosis.
    Wolde K, Lema E, Roscigno G, Abdi A.
    Ethiop Med J; 1992 Apr; 30(2):63-8. PubMed ID: 1345030
    [Abstract] [Full Text] [Related]

  • 10. [Long-term results of short-course chemotherapy in pulmonary tuberculosis (final report). The third study: comparative study of two regimens, 6RHZ and -6RHS (treatment was continued for 6 months after negative conversion of sputum by culture)].
    Baba H, Shinkai A, Izuchi R, Azuma Y.
    Kekkaku; 1988 Apr; 63(4):239-46. PubMed ID: 3136270
    [No Abstract] [Full Text] [Related]

  • 11. [Follow-up observation on relapse of smear negative pulmonary tuberculosis after short-course chemotherapy].
    Xu WG, Gao Z, Fan BD.
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):74-6. PubMed ID: 12783655
    [Abstract] [Full Text] [Related]

  • 12. [Analysis of short-term effects of short-course intermittent chemotherapies of the World Bank Loaned Project].
    Wen S, Su Y, Zhang F.
    Zhonghua Jie He He Hu Xi Za Zhi; 1996 Dec; 19(6):357-9. PubMed ID: 9596819
    [Abstract] [Full Text] [Related]

  • 13. [The operational control studies of smear positive tuberculosis cases with short-course chemotherapy under the full-course management and supervision].
    Dai YS, Li Q, Duanmu HJ.
    Zhonghua Jie He He Hu Xi Za Zhi; 1994 Oct; 17(5):278-80, 318. PubMed ID: 7712567
    [Abstract] [Full Text] [Related]

  • 14. [Studies on sputum conversion of smear-positive, previously untreated pulmonary tuberculosis: a comparison of short-course and standard chemotherapy regimens].
    Huang M.
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Feb; 9(1):1-5, 61. PubMed ID: 3743274
    [No Abstract] [Full Text] [Related]

  • 15. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, Rüsch-Gerdes S.
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [Abstract] [Full Text] [Related]

  • 16. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M, Bek E.
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract] [Full Text] [Related]

  • 17. [Long-term efficacy of full course intermittent short-course chemotherapy on new smear positive tuberculosis patients].
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Jun; 20(3):164-6. PubMed ID: 10072822
    [Abstract] [Full Text] [Related]

  • 18. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
    Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
    [No Abstract] [Full Text] [Related]

  • 19. [Chemotherapy with isoniazid and rifampicin for pulmonary tuberculosis].
    Kawakami K.
    Kekkaku; 2002 Aug; 77(8):569-71. PubMed ID: 12235849
    [Abstract] [Full Text] [Related]

  • 20. [Efficiency of an intensive stage of chemotherapy for tuberculosis in elderly and senile patients].
    Karachunskiĭ MA, Uvarova TE.
    Probl Tuberk Bolezn Legk; 2004 Aug; (3):19-21. PubMed ID: 15338894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.